The findings of our study indicate that exogenous administration of G-CSF promotes cell proliferation and induces resistance to cisplatin in breast cancer cell lines, including both MCF-7 and MDA-MB-231 subtypes. This evidence concerns the gene CSF3 and breast carcinoma.